Position in NBIX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$2,766,415
+$490,344 QoQ
Shares Held
16,414
-5.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#274
of 768 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ASSETMARK, INC holds $375,029,634 across 23 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
624,068 | $338,138,764 | |
| 2 | ZTS |
Zoetis Inc.
|
282,029 | $20,266,603 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
314,687 | $5,044,432 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
16,414 | $2,766,415 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
81,250 | $2,752,750 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
49,713 | $2,312,151 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
68,590 | $1,384,146 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
12,110 | $1,343,483 |
All Filings in NBIX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,766,415 | 16,414 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,276,071 | 17,277 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $2,740,297 | 19,321 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,840,729 | 20,236 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,639,615 | 21,001 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $2,096,533 | 18,956 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,718,261 | 19,914 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,111,176 | 18,323 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,281,191 | 16,570 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,670,211 | 12,110 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $4,869,190 | 36,955 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,181,162 | 28,277 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $2,256,316 | 23,927 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,001,726 | 19,776 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $2,134,751 | 17,873 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,742,056 | 16,402 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $1,313,348 | 13,473 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $858,375 | 9,156 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $431,215 | 5,063 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $141,754 | 1,478 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||